Centessa Pharmaceuticals plc ADR (NASDAQ:CNTA) shares, rose in value, with the stock price up by 3.86% to the previous day’s close as strong demand from buyers drove the stock to $16.96.
Actively observing the price movement in the last trading, the stock closed the session at $16.33. Referring to stock’s 52-week performance, its high was $19.09, and the low was $7.75. On the whole, CNTA has fluctuated by 0.36% over the past month.
With the market capitalization of Centessa Pharmaceuticals plc ADR currently standing at about $2.23 billion, investors are eagerly awaiting this quarter’s results, scheduled for in April.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CNTA’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the price of CNTA currently trading nearly 1.66% and 2.30% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 53.63, while the 7-day volatility ratio is showing 8.48% which for the 30-day chart, stands at 7.61%. Furthermore, Centessa Pharmaceuticals plc ADR (CNTA)’s beta value is 1.51, and its average true range (ATR) is 1.21.
A comparison of Centessa Pharmaceuticals plc ADR (CNTA) with its peers suggests the former has fared considerably weaker in the market. CNTA showed an intraday change of 3.86% in last session, and over the past year, it grew by 56.03%%. In comparison, Johnson & Johnson (JNJ) has moved lower at -0.18%% on the day and was up 3.63% over the past 12 months. On the other hand, the price of Banco Santander S.A. ADR (SAN) has risen 4.24%% on the day. The stock, however, is off 58.10% from where it was a year ago.
Data on historical trading for Centessa Pharmaceuticals plc ADR (NASDAQ:CNTA) indicates that the trading volumes over the past 3 months, they’ve averaged 757.61K. According to company’s latest data on outstanding shares, there are 131.66 million shares outstanding.
Nearly 39.43% of Centessa Pharmaceuticals plc ADR’s shares belong to company insiders and institutional investors own 55.19% of the company’s shares. The stock has risen by 1.25% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CNTA stock heading into the next quarter.
